These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14968807)

  • 21. N-methyl-D-aspartate receptor channel blockers prevent pentylenetetrazole-induced convulsions and morphological changes in rat brain neurons.
    Zaitsev AV; Kim KKh; Vasilev DS; Lukomskaya NY; Lavrentyeva VV; Tumanova NL; Zhuravin IA; Magazanik LG
    J Neurosci Res; 2015 Mar; 93(3):454-65. PubMed ID: 25359451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of hippocampal markers of synaptic plasticity by memantine in animal models of acute and repeated restraint stress: implications for memory and behavior.
    Amin SN; El-Aidi AA; Ali MM; Attia YM; Rashed LA
    Neuromolecular Med; 2015 Jun; 17(2):121-36. PubMed ID: 25680935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classics in Chemical Neuroscience: Memantine.
    Alam S; Lingenfelter KS; Bender AM; Lindsley CW
    ACS Chem Neurosci; 2017 Sep; 8(9):1823-1829. PubMed ID: 28737885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine.
    Vorwerk CK; Lipton SA; Zurakowski D; Hyman BT; Sabel BA; Dreyer EB
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1618-24. PubMed ID: 8675405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanisms of action of Alzheimer medications].
    Alhainen K
    Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
    [No Abstract]   [Full Text] [Related]  

  • 26. American Chemical Society--227th Annual Meeting. NMDA receptor. 28 March - 1 April 2004, Anaheim, CA, USA.
    Rotella DP
    IDrugs; 2004 May; 7(5):433-5. PubMed ID: 15154102
    [No Abstract]   [Full Text] [Related]  

  • 27. Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementias.
    Molinuevo JL; Lladó A; Rami L
    Am J Alzheimers Dis Other Demen; 2005; 20(2):77-85. PubMed ID: 15844753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Bochenski M
    Eur J Pharmacol; 2008 Nov; 598(1-3):57-63. PubMed ID: 18838071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action of memantine.
    Johnson JW; Kotermanski SE
    Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memantine: the next trend in academic performance enhancement?
    Ota KS; Godwin T
    J Am Osteopath Assoc; 2006 Jun; 106(6):358-9. PubMed ID: 16790543
    [No Abstract]   [Full Text] [Related]  

  • 31. Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
    Kornhuber J; Weller M; Schoppmeyer K; Riederer P
    J Neural Transm Suppl; 1994; 43():91-104. PubMed ID: 7884411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors.
    Marino MJ; Conn PJ
    Curr Opin Pharmacol; 2006 Feb; 6(1):98-102. PubMed ID: 16368268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
    Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
    J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between metabotropic and NMDA glutamate receptors in the periaqueductal grey pain modulatory system.
    Berrino L; Oliva P; Rossi F; Palazzo E; Nobili B; Maione S
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):437-43. PubMed ID: 11692227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Memantine].
    Molinuevo JL
    Neurologia; 2003 Jun; 18(5):255-61. PubMed ID: 12768511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YM 900. YM 90K.
    Drugs R D; 1999 Jan; 1(1):42-3. PubMed ID: 10565984
    [No Abstract]   [Full Text] [Related]  

  • 37. Memantine hydrochloride.
    Witt A; Macdonald N; Kirkpatrick P
    Nat Rev Drug Discov; 2004 Feb; 3(2):109-10. PubMed ID: 15040575
    [No Abstract]   [Full Text] [Related]  

  • 38. From tau to toxicity: emerging roles of NMDA receptor in Alzheimer's disease.
    Chohan MO; Iqbal K
    J Alzheimers Dis; 2006 Sep; 10(1):81-7. PubMed ID: 16988485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic insights into the efficacy of memantine in treating certain drug addictions.
    Montemitro C; Angebrandt A; Wang TY; Pettorruso M; Abulseoud OA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110409. PubMed ID: 34324921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Pharmacological Potency and Safety of Glutamate Blocker IEM-1913 and Memantine.
    Gmiro VE; Serdyuk SE; Veselkina OS
    Bull Exp Biol Med; 2015 Nov; 160(1):68-71. PubMed ID: 26601831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.